PT1154759E - Concentrado dispersível para administração de ciclosporina - Google Patents
Concentrado dispersível para administração de ciclosporina Download PDFInfo
- Publication number
- PT1154759E PT1154759E PT99961269T PT99961269T PT1154759E PT 1154759 E PT1154759 E PT 1154759E PT 99961269 T PT99961269 T PT 99961269T PT 99961269 T PT99961269 T PT 99961269T PT 1154759 E PT1154759 E PT 1154759E
- Authority
- PT
- Portugal
- Prior art keywords
- surfactant
- formulation
- cyclosporin
- less
- delivery
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 2
- 229930105110 Cyclosporin A Natural products 0.000 title abstract 2
- 108010036949 Cyclosporine Proteins 0.000 title abstract 2
- 229960001265 ciclosporin Drugs 0.000 title abstract 2
- 229930182912 cyclosporin Natural products 0.000 title abstract 2
- 239000004491 dispersible concentrate Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 239000004094 surface-active agent Substances 0.000 abstract 4
- -1 fatty acid ester Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 239000008389 polyethoxylated castor oil Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 abstract 1
- 229940093633 tricaprin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22337898A | 1998-12-30 | 1998-12-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1154759E true PT1154759E (pt) | 2008-11-20 |
Family
ID=22836258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99961269T PT1154759E (pt) | 1998-12-30 | 1999-12-30 | Concentrado dispersível para administração de ciclosporina |
Country Status (12)
Country | Link |
---|---|
US (1) | US7026290B1 (pt) |
EP (1) | EP1154759B1 (pt) |
JP (1) | JP2002534370A (pt) |
AT (1) | ATE404172T1 (pt) |
AU (1) | AU769429C (pt) |
CA (1) | CA2358448C (pt) |
DE (1) | DE69939335D1 (pt) |
DK (1) | DK1154759T3 (pt) |
IL (1) | IL143604A0 (pt) |
NZ (1) | NZ512599A (pt) |
PT (1) | PT1154759E (pt) |
WO (1) | WO2000040219A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9912476D0 (en) | 1999-05-28 | 1999-07-28 | Novartis Ag | Organic compounds |
KR100801588B1 (ko) * | 1999-09-21 | 2008-02-05 | 스키에파마 캐나다 인코포레이티드 | 생물학적 유효 물질의 표면 변형된 미립자 조성물 |
AU2006201100B2 (en) * | 1999-09-21 | 2009-09-24 | Jagotec Ag | Surface modified particulate compositions of biologically active substances |
US7732404B2 (en) * | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
US7919113B2 (en) * | 1999-12-30 | 2011-04-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Dispersible concentrate lipospheres for delivery of active agents |
AUPR510001A0 (en) * | 2001-05-18 | 2001-06-14 | Jupitar Pty Ltd | Formulation and method |
HUP0400263A2 (hu) | 2001-06-21 | 2005-03-29 | Pfizer Products Inc. | Koleszteril-észter transzfer protein inhibitort tartalmazó önemulgeáló készítmény |
AU2002952597A0 (en) * | 2002-11-11 | 2002-11-28 | Schering-Plough Pty. Limited | Topical parasiticide formulations and methods of treatment |
DE102006051512A1 (de) * | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
DE102006050026A1 (de) * | 2006-10-13 | 2008-04-17 | Bio Mac- Privatinstitut für medizinische und zahnmedizinische Forschung, Entwicklung und Diagnostik GmbH | Verwendung von Verbindungen und pharmazeutische Zusammensetzung zur Suppression des Immunsystems |
GB0623838D0 (en) * | 2006-11-29 | 2007-01-10 | Malvern Cosmeceutics Ltd | Novel compositions |
GB2451811A (en) * | 2007-08-09 | 2009-02-18 | Ems Sa | Delivery composition for solubilising water-insoluble pharmaceutical active ingredients |
JP5668476B2 (ja) * | 2007-10-08 | 2015-02-12 | オーリニア・ファーマシューティカルズ・インコーポレイテッドAurinia Pharmaceuticals Inc. | カルシニューリン阻害剤またはmTOR阻害剤を含む眼科用組成物 |
WO2010144194A1 (en) | 2009-06-09 | 2010-12-16 | Lux Biosciences, Inc. | Topical drug delivery systems for ophthalmic use |
KR101586791B1 (ko) * | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
US20150352176A1 (en) * | 2014-06-06 | 2015-12-10 | Newport Research, Inc. | Oil-free and fat-free aqueous suspensions of cyclosporin |
US11324800B2 (en) | 2015-01-15 | 2022-05-10 | Wellspring Ophthalmics, Inc. | Aqueous suspensions of cyclosporin |
US20200237859A1 (en) | 2019-01-25 | 2020-07-30 | Newport Research, Inc. | Aqueous suspensions of cyclosporin |
US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4117118A (en) | 1976-04-09 | 1978-09-26 | Sandoz Ltd. | Organic compounds |
FI65914C (fi) | 1978-03-07 | 1984-08-10 | Sandoz Ag | Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a |
US4215199A (en) | 1978-06-05 | 1980-07-29 | Sandoz Ltd. | Antibiotic production |
IE54936B1 (en) | 1980-02-14 | 1990-03-28 | Sandoz Ltd | A method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production |
US5639724A (en) | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
US4861580A (en) | 1985-10-15 | 1989-08-29 | The Liposome Company, Inc. | Composition using salt form of organic acid derivative of alpha-tocopheral |
US5154930A (en) | 1987-03-05 | 1992-10-13 | The Liposome Company, Inc. | Pharmacological agent-lipid solution preparation |
KR880012221A (ko) | 1987-04-13 | 1988-11-26 | 사노 가즈오 | 에스테르 또는 아미드를 활성성분으로 함유하는 약제 조성물 |
ATE95193T1 (de) | 1987-06-17 | 1993-10-15 | Sandoz Ag | Cyclosporine und deren benutzung als arzneimittel. |
US5756450A (en) | 1987-09-15 | 1998-05-26 | Novartis Corporation | Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms |
US4814168A (en) | 1988-03-04 | 1989-03-21 | Noven Pharmaceuticals, Inc. | Transdermal multipolymer drug delivery system |
US4994267A (en) | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
GB8809616D0 (en) | 1988-04-22 | 1988-05-25 | Cancer Res Campaign Tech | Further improvements relating to drug delivery systems |
US5342625A (en) | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
KR0148748B1 (ko) | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
SE8804164A0 (sv) | 1988-11-17 | 1990-05-18 | Per Prisell | Farmaceutisk beredning |
HU201577B (en) | 1988-12-20 | 1990-11-28 | Gyogyszerkutato Intezet | Process for producing cyclosporin antibiotics |
EP0388152B1 (en) | 1989-03-15 | 1994-10-12 | Merck & Co. Inc. | Process for producing an immunosuppressant agent (demethimmunomycin) using a mutant strain of a microorganism |
US5272068A (en) | 1989-03-15 | 1993-12-21 | Merck & Co., Inc. | Process for producing immunosuppressant agent L-683942 by fermentation |
US5227165A (en) | 1989-11-13 | 1993-07-13 | Nova Pharmaceutical Corporation | Liposphere delivery systems for local anesthetics |
IE904098A1 (en) | 1989-11-13 | 1991-05-22 | Nova Pharm Corp | Lipospheres for controlled delivery of substances |
US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
US5178866A (en) | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
EP0484281B2 (en) | 1990-11-02 | 2000-11-22 | Novartis AG | Cyclosporins |
HU208491B (en) | 1990-11-27 | 1993-11-29 | Gyogyszerkutato Intezet | Process for producing oral pharmaceutical composition containing cyclosporin |
WO1992013094A1 (fr) | 1991-01-25 | 1992-08-06 | Fujisawa Pharmaceutical Co., Ltd. | Procede pour produire de la cyclosporine a et/ou c |
US5378475A (en) | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5683714A (en) | 1991-04-19 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Liposomal cyclosporin pharmaceutical formulation |
DE69211691T2 (de) | 1991-04-19 | 1997-01-16 | Nexstar Pharmaceuticals Inc | Pharmazeutische formulierung und pharmazeutisches verfahren |
IL101007A (en) | 1992-02-18 | 1997-08-14 | Pharmos Ltd | Dry stable compositions prepared by lyophilization |
US5637317A (en) | 1992-05-18 | 1997-06-10 | Dietl; Hans | Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same |
US5529785A (en) | 1993-05-12 | 1996-06-25 | Dietl; Hans | Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same |
HU213553B (en) | 1992-05-25 | 1997-07-28 | Biogal Gyogyszergyar | Process for isolating of cyclosporin-a |
US5759566A (en) | 1992-07-28 | 1998-06-02 | Poli Industria Chimica Spa | Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents |
CZ278863B6 (en) | 1992-09-07 | 1994-07-13 | Galena | Medicinal preparations with n-methylated cyclic undecapeptides |
FI92334C (fi) | 1992-12-30 | 1994-10-25 | Leiras Oy | Menetelmä syklosporiinien tuottamiseksi ja menetelmässä käytettävä uusi Tolypocladium-kanta |
JP3489831B2 (ja) | 1993-04-20 | 2004-01-26 | ヘクサル・アクチエンゲゼルシャフト | 活性成分パッチ |
US5576016A (en) | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
CH686761A5 (de) | 1993-05-27 | 1996-06-28 | Sandoz Ag | Galenische Formulierungen. |
US5639474A (en) | 1993-07-01 | 1997-06-17 | Hanmi Pharm. Ind., Ltd. | Cyclosporin soft capsule composition |
SI0649651T1 (en) | 1993-09-28 | 2001-02-28 | Scherer Gmbh R P | Soft gelatin capsule manufacture |
DE4340781C3 (de) | 1993-11-30 | 2000-01-27 | Novartis Ag | Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung |
PL178397B1 (pl) * | 1994-02-04 | 2000-04-28 | Scotia Lipidteknik Ab | Emulsja typu olej w wodzie i środek farmaceutyczny zawierający emulsję typu olej w wodzie |
US5891846A (en) | 1994-02-17 | 1999-04-06 | Shiseido Company, Ltd. | Cyclosporin-containing emulsion composition |
KR0146671B1 (ko) | 1994-02-25 | 1998-08-17 | 김충환 | 사이클로스포린-함유 분말 조성물 |
GB9405304D0 (en) | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
US5430021A (en) | 1994-03-18 | 1995-07-04 | Pharmavene, Inc. | Hydrophobic drug delivery systems |
US5651980A (en) | 1994-04-15 | 1997-07-29 | Biohybrid Technologies, Inc. | Methods of use of uncoated gel particles |
WO1995032726A1 (en) | 1994-06-01 | 1995-12-07 | Yuhan Corporation | Cyclosporin containing composition and process for the preparation thereof |
US5958458A (en) | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
KR100304324B1 (ko) | 1994-10-13 | 2001-11-22 | 김용규 | 사이클로스포린a의제조방법 |
KR0126610B1 (ko) | 1994-10-18 | 1997-12-29 | 김충환 | 고생산 세포융합변이균주에 의한 사이클로스포린 a의 제조방법 |
US5603951A (en) | 1994-11-09 | 1997-02-18 | Hanmi Pharm. Ind. Co., Ltd. | Cyclosporin-containing soft capsule compositions |
DE4440337A1 (de) | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
HU215966B (hu) | 1994-11-21 | 1999-07-28 | BIOGAL Gyógyszergyár Rt. | Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum |
KR0167613B1 (ko) | 1994-12-28 | 1999-01-15 | 한스 루돌프 하우스, 니콜 케르커 | 사이클로스포린-함유 연질캅셀제 조성물 |
EP0725076B1 (en) | 1995-02-01 | 2001-06-06 | National Research Development Corporation of India | A process for the preparation of cyclosporin A from tolypocladium species |
US5573783A (en) | 1995-02-13 | 1996-11-12 | Nano Systems L.L.C. | Redispersible nanoparticulate film matrices with protective overcoats |
FI102758B (fi) | 1995-03-03 | 1999-02-15 | Santen Pharmaceutical Co Ltd | Menetelmä puhtaan syklosporiinimuodon valmistamiseksi |
IE75744B1 (en) | 1995-04-03 | 1997-09-24 | Elan Corp Plc | Controlled release biodegradable micro- and nanospheres containing cyclosporin |
WO1996033697A1 (fr) | 1995-04-24 | 1996-10-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Formulation auto-emulsionnable formant une emulsion huile dans l'eau |
US5716928A (en) | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US5616595A (en) | 1995-06-07 | 1997-04-01 | Abbott Laboratories | Process for recovering water insoluble compounds from a fermentation broth |
US5665386A (en) | 1995-06-07 | 1997-09-09 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US5656287A (en) | 1995-06-07 | 1997-08-12 | Nexstar Pharmaceuticals, Inc. | Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications |
US5827822A (en) | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
US5962019A (en) | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
EP0760237A1 (en) | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
US5968972A (en) | 1995-10-26 | 1999-10-19 | Baker Norton Pharmaceuticals, Inc. | Method for increasing the oral bioactivity of pharmaceutical agents |
NZ280689A (en) | 1995-12-15 | 1997-08-22 | Bernard Charles Sherma Sherman | Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol |
KR970064620A (ko) * | 1996-03-05 | 1997-10-13 | 임성기 | 사이클로스포린-함유 외용약제 조성물 |
DE19611094C2 (de) | 1996-03-21 | 1999-06-17 | Dresden Arzneimittel | Verfahren zur Reinigung von Cyclosporin A und/oder verwandten Cyclosporinen aus einem Cyclosporin-haltigen Rohextrakt unter Anwendung chromatographischer Verfahren mit Kieselgel als Adsorbens |
IL117773A (en) | 1996-04-02 | 2000-10-31 | Pharmos Ltd | Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability |
US5660858A (en) | 1996-04-03 | 1997-08-26 | Research Triangle Pharmaceuticals | Cyclosporin emulsions |
US5747330A (en) | 1996-06-05 | 1998-05-05 | Poli Industria Chimica | Antibiotic producing microbe |
US5709797A (en) | 1996-06-05 | 1998-01-20 | Poli Industria Chimica S.P.A. | Method of isolating cyclosporins |
US5958876A (en) | 1996-06-19 | 1999-09-28 | Novartis Ag | Cyclosporin-containing pharmaceutical compositions |
US5958378A (en) | 1996-07-03 | 1999-09-28 | Research Development Foundation | High dose liposomal aerosol formulations containing cyclosporin A or budesonide |
KR980008239A (ko) | 1996-07-26 | 1998-04-30 | 김충환 | 사이클로스포린-함유 약학적 조성물 |
US5798333A (en) | 1996-09-17 | 1998-08-25 | Sherman; Bernard C. | Water-soluble concentrates containing cyclosporins |
CA2284000C (en) | 1997-03-12 | 2012-01-03 | Abbott Laboratories | Hydrophilic binary systems for the administration of cyclosporine |
US5891845A (en) | 1997-11-21 | 1999-04-06 | Fuisz Technologies Ltd. | Drug delivery systems utilizing liquid crystal structures |
US6028067A (en) * | 1997-12-05 | 2000-02-22 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
ID25908A (id) * | 1998-03-06 | 2000-11-09 | Novartis Ag | Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida |
FR2780061B1 (fr) | 1998-06-22 | 2001-09-07 | Rhone Poulenc Rorer Sa | Nouveau procede de preparation de derives de cyclosporine |
US6267985B1 (en) | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
US6057289A (en) | 1999-04-30 | 2000-05-02 | Pharmasolutions, Inc. | Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system |
HUP0400263A2 (hu) * | 2001-06-21 | 2005-03-29 | Pfizer Products Inc. | Koleszteril-észter transzfer protein inhibitort tartalmazó önemulgeáló készítmény |
-
1999
- 1999-12-30 DE DE69939335T patent/DE69939335D1/de not_active Expired - Lifetime
- 1999-12-30 WO PCT/IL1999/000710 patent/WO2000040219A1/en active IP Right Grant
- 1999-12-30 DK DK99961269T patent/DK1154759T3/da active
- 1999-12-30 IL IL14360499A patent/IL143604A0/xx active IP Right Grant
- 1999-12-30 NZ NZ512599A patent/NZ512599A/en not_active IP Right Cessation
- 1999-12-30 AT AT99961269T patent/ATE404172T1/de active
- 1999-12-30 US US09/869,519 patent/US7026290B1/en not_active Expired - Fee Related
- 1999-12-30 AU AU17962/00A patent/AU769429C/en not_active Expired
- 1999-12-30 CA CA002358448A patent/CA2358448C/en not_active Expired - Fee Related
- 1999-12-30 PT PT99961269T patent/PT1154759E/pt unknown
- 1999-12-30 JP JP2000591976A patent/JP2002534370A/ja active Pending
- 1999-12-30 EP EP99961269A patent/EP1154759B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL143604A0 (en) | 2002-04-21 |
DK1154759T3 (da) | 2008-12-08 |
JP2002534370A (ja) | 2002-10-15 |
ATE404172T1 (de) | 2008-08-15 |
EP1154759A1 (en) | 2001-11-21 |
AU769429C (en) | 2004-10-28 |
NZ512599A (en) | 2003-10-31 |
US7026290B1 (en) | 2006-04-11 |
CA2358448C (en) | 2009-02-10 |
DE69939335D1 (de) | 2008-09-25 |
WO2000040219A1 (en) | 2000-07-13 |
AU1796200A (en) | 2000-07-24 |
EP1154759A4 (en) | 2005-07-20 |
AU769429B2 (en) | 2004-01-29 |
EP1154759B1 (en) | 2008-08-13 |
CA2358448A1 (en) | 2000-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1154759E (pt) | Concentrado dispersível para administração de ciclosporina | |
US7070802B1 (en) | Pharmaceutical compositions for lipophilic drugs | |
CA2250970C (en) | Cyclosporin emulsions | |
AU2002356137B2 (en) | Spontaneous emulsions containing cyclosporine | |
US6054136A (en) | Orally administrable composition capable of providing enhanced bioavailability when ingested | |
DK1682091T3 (en) | COMPOSITIONS OF LIPIDS AND CATIONIC PEPTIDES | |
FR2710535B1 (fr) | Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion. | |
GB9608719D0 (en) | Pharmaceutical compositions | |
SI9500350B (sl) | Oralni multipli emulzijski predkoncentrat | |
KR960021056A (ko) | 사이클로스포린-함유 연질캅셀제 조성물 | |
WO1999056727A2 (en) | Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems | |
WO1994008610A1 (en) | Pharmaceutical emulsion compositions | |
KR960016904A (ko) | 사이클로스포린-함유 연질캅셀제 조성물 | |
KR970064620A (ko) | 사이클로스포린-함유 외용약제 조성물 | |
AU2003248969A1 (en) | Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant | |
KR970706803A (ko) | 경구용 시클로스포린 제형(oral cyclosporin formulations) | |
KR100426346B1 (ko) | 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물 | |
Hasan et al. | Development of potential selfmicroemulsifying lipid formulation for the oral administration of curcumin | |
JPH0570793A (ja) | 脂質の粒状組成物 | |
JP2003321338A (ja) | 乳化化粧料 | |
JPH10298109A (ja) | 乳剤用保存剤および乳剤 | |
MXPA99006916A (en) | Oil-free pharmaceutical compositions containing cyclosporin a |